These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 16983341)

  • 1. Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development.
    Szabo R; Molinolo A; List K; Bugge TH
    Oncogene; 2007 Mar; 26(11):1546-56. PubMed ID: 16983341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte growth factor activator inhibitor-1 (HAI-1) is essential for the integrity of basement membranes in the developing placental labyrinth.
    Fan B; Brennan J; Grant D; Peale F; Rangell L; Kirchhofer D
    Dev Biol; 2007 Mar; 303(1):222-30. PubMed ID: 17174946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta.
    Tanaka H; Nagaike K; Takeda N; Itoh H; Kohama K; Fukushima T; Miyata S; Uchiyama S; Uchinokura S; Shimomura T; Miyazawa K; Kitamura N; Yamada G; Kataoka H
    Mol Cell Biol; 2005 Jul; 25(13):5687-98. PubMed ID: 15964823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced prostasin (CAP1/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activation.
    Szabo R; Uzzun Sales K; Kosa P; Shylo NA; Godiksen S; Hansen KK; Friis S; Gutkind JS; Vogel LK; Hummler E; Camerer E; Bugge TH
    PLoS Genet; 2012; 8(8):e1002937. PubMed ID: 22952456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity.
    Szabo R; Hobson JP; List K; Molinolo A; Lin CY; Bugge TH
    J Biol Chem; 2008 Oct; 283(43):29495-504. PubMed ID: 18713750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells.
    Kohama K; Kawaguchi M; Fukushima T; Lin CY; Kataoka H
    Hum Cell; 2012 Dec; 25(4):100-10. PubMed ID: 23248048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters.
    Oberst MD; Johnson MD; Dickson RB; Lin CY; Singh B; Stewart M; Williams A; al-Nafussi A; Smyth JF; Gabra H; Sellar GC
    Clin Cancer Res; 2002 Apr; 8(4):1101-7. PubMed ID: 11948120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor activator inhibitor-1 has a complex subcellular itinerary.
    Godiksen S; Selzer-Plon J; Pedersen ED; Abell K; Rasmussen HB; Szabo R; Bugge TH; Vogel LK
    Biochem J; 2008 Jul; 413(2):251-9. PubMed ID: 18402552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1.
    Kirchhofer D; Peek M; Li W; Stamos J; Eigenbrot C; Kadkhodayan S; Elliott JM; Corpuz RT; Lazarus RA; Moran P
    J Biol Chem; 2003 Sep; 278(38):36341-9. PubMed ID: 12815039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defect of hepatocyte growth factor activator inhibitor type 1/serine protease inhibitor, Kunitz type 1 (Hai-1/Spint1) leads to ichthyosis-like condition and abnormal hair development in mice.
    Nagaike K; Kawaguchi M; Takeda N; Fukushima T; Sawaguchi A; Kohama K; Setoyama M; Kataoka H
    Am J Pathol; 2008 Nov; 173(5):1464-75. PubMed ID: 18832587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptase.
    Kojima K; Tsuzuki S; Fushiki T; Inouye K
    J Biol Chem; 2008 Feb; 283(5):2478-87. PubMed ID: 18048349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor activator inhibitor type 2 (HAI-2) modulates hepcidin expression by inhibiting the cell surface protease matriptase-2.
    Maurer E; Gütschow M; Stirnberg M
    Biochem J; 2013 Mar; 450(3):583-93. PubMed ID: 23293962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo.
    Oberst M; Anders J; Xie B; Singh B; Ossandon M; Johnson M; Dickson RB; Lin CY
    Am J Pathol; 2001 Apr; 158(4):1301-11. PubMed ID: 11290548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice.
    Szabo R; Hobson JP; Christoph K; Kosa P; List K; Bugge TH
    Development; 2009 Aug; 136(15):2653-63. PubMed ID: 19592578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte growth factor activator inhibitor-2 prevents shedding of matriptase.
    Larsen BR; Steffensen SD; Nielsen NV; Friis S; Godiksen S; Bornholdt J; Soendergaard C; Nonboe AW; Andersen MN; Poulsen SS; Szabo R; Bugge TH; Lin CY; Skovbjerg H; Jensen JK; Vogel LK
    Exp Cell Res; 2013 Apr; 319(6):918-29. PubMed ID: 23333561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor activator inhibitor type 1 inhibits protease activity and proteolytic activation of human airway trypsin-like protease.
    Kato M; Hashimoto T; Shimomura T; Kataoka H; Ohi H; Kitamura N
    J Biochem; 2012 Feb; 151(2):179-87. PubMed ID: 22023801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.
    Friis S; Sales KU; Schafer JM; Vogel LK; Kataoka H; Bugge TH
    J Biol Chem; 2014 Aug; 289(32):22319-32. PubMed ID: 24962579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of matriptase suppression underlies spint1 mutation-associated ichthyosis and postnatal lethality.
    Szabo R; Kosa P; List K; Bugge TH
    Am J Pathol; 2009 Jun; 174(6):2015-22. PubMed ID: 19389929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases.
    Cheng H; Fukushima T; Takahashi N; Tanaka H; Kataoka H
    Cancer Res; 2009 Mar; 69(5):1828-35. PubMed ID: 19223533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential subcellular localization renders HAI-2 a matriptase inhibitor in breast cancer cells but not in mammary epithelial cells.
    Chang HH; Xu Y; Lai H; Yang X; Tseng CC; Lai YJ; Pan Y; Zhou E; Johnson MD; Wang JK; Lin CY
    PLoS One; 2015; 10(3):e0120489. PubMed ID: 25786220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.